Therapeutics

Surprise! Pharma says their “digital resources” are good for consumers

by

Sirensong Reliance on pharma-sponsored digital resources among online U.S. adults is significant. The research found “51% of online U.S. adults (ages 18+) use pharma-sponsored digital resources, such as condition and treatment information, disease management tools, doctor discussion guides, or mobile apps or websites.” This validates that the interactive information and tools produced by biopharma are … Read more

Impact of Anti-infective Drug Shortages [Article]

by

Clinical Infectious Disease (online January 19): Abstract Anti-infective shortages pose significant logistical and clinical challenges to hospitals and may be considered a public health emergency. Anti-infectives often represent irreplaceable life-saving treatments. Furthermore, few new agents are available to treat increasingly prevalent multidrug-resistant pathogens. Frequent anti-infective shortages have substantially altered patient care and may lead to … Read more

The e-patient movement, panacea or barrier to care?

by

I haven’t really paid much attention to the e-patient movement, but recently it’s become a subject of interest.

I Googled “epatient”, and here’s what I found: “e-Patients are health consumers who use the Internet to gather information about a medical condition of particular interest to them, and who use electronic communication tools in coping with medical conditions The term encompasses both those who seek online guidance for their own ailments and the friends and family members who go online on their behalf. e-Patients report two effects of their online health research: “better health information and services, and different (but not always better) relationships with their doctors.”” This definition comes from Wikipedia. I’m not a big fan of Wikipedia, but in this case it seems appropriate.

Read more

Fun with Lugol’s solution…not really

by

A recent ISMP Medication Safety Alert shared various errors that have occurred with Lugol’s solution over the ages. Lugol’s solution is a concentrated liquid form of potassium iodide and iodine known for its use in the treatment of hyperthyroidism. It’s also a dangerous drug because it’s typically dosed in drops, not mL’s. Anyway, the ISMP … Read more

National Influenza Vaccination Week December 4-10

by

imageApparently National Influenza Vaccination Week (NIVW) is next week. Who knew?

The CDC has additional information on NIVW here, and a whole lot more information on seasonal influenza (Flu) as well. Need to know more about types of influenza viruses? No problem, you can find that at the CDC site too. The most common form of influenza is Type A. For most healthy people the flu is self-limiting. Sure you feel like crap for a few days, but you get over it and truck on. With that said, influenza can be quite dangerous to elderly and those with compromised immune systems. Get vaccinated.

Read more

Pharmacists impact on osteoporosis management (review article)

by

Pharmacists are pretty good at helping people with chronic medical conditions manage their medications, hence the term Medication Therapy Managment (MTM). You can find more information about MTM at the American Pharmacists Association (APhA) website. Anyway, I came across an article this morning that gives the results of a literature review “to examine the impact … Read more

Bacteria everywhere run scared as vancomycin gets new life

by

medGadget: “Scientists from the Scripps Research Institute have successfully reengineered vancomycin. They have reported their findings in the Journal of the American Chemical Society. This research could be a solution in the treatment of patients infected with highly resistant bacteria. Vancomycin is often considered the antiobiotic of last resort, if other antibiotics have failed to … Read more